Cutler Group LP Nrx Pharmaceuticals, Inc. Transaction History

Cutler Group LP

  • $307 Million
  • Q1 2024

A detailed history of Cutler Group LP transactions in Nrx Pharmaceuticals, Inc. stock. As of the latest transaction made, Cutler Group LP holds 3,220 shares of NRXP stock, worth $5,538. This represents 0.0% of its overall portfolio holdings.

Number of Shares
3,220
Previous 3,220 -0.0%
Holding current value
$5,538
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

Apr 14, 2022
SELL
$2.45 - $5.04 $9,307 - $19,146
-3,799 Reduced 54.12%
3,220 $7,000
Q4 2021

Jan 18, 2022
SELL
$4.5 - $11.91 $1,944 - $5,145
-432 Reduced 5.8%
7,019 $33,000
Q3 2021

Oct 26, 2021
BUY
$8.52 - $24.77 $63,482 - $184,561
7,451 New
7,451 $69,000

Others Institutions Holding NRXP

# of Institutions
2
Shares Held
17.4K
Call Options Held
0
Put Options Held
0
View Full List

About NRX Pharmaceuticals, Inc.

NRXP Quotes by TradingView
  • Ticker NRXP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 67,641,296
  • Market Cap $116M
  • Description
  • NRX Pharmaceuticals, Inc., a clinical-stage pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. Its products include ZYESAMI, an investigational drug that has completed a Phase IIb/III clinical study for COVID-19 related respiratory failure; and NRX-10...
More about NRXP
Track This Portfolio

Track Cutler Group LP Portfolio

Follow Cutler Group LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

News

Stay updated on Cutler Group LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email